Emerald Health Therapeutics Announces $25 Million Convertible Debenture Unit Financing VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subject to
[Read More ...]
from
https://www.newcannabisventures.com/emerald-health-to-sell-25-million-2-convertible-notes-with-12-5-million-2-warrants/
No comments:
Post a Comment